JAK2 V617F in myeloid disorders: what do we know now, and where are we headed?

ME Nelson, DP Steensma - Leukemia & lymphoma, 2006 - Taylor & Francis
Activating tyrosine kinase (TK) mutations disrupt cellular proliferation and survival pathways
and are increasingly recognized as a fundamental cause of human cancers. Until very …

JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow …

T Mercher, G Wernig, SA Moore, RL Levine, TL Gu… - Blood, 2006 - ashpublications.org
Acute megakaryoblastic leukemia (AMKL) is a subtype of acute myeloid leukemia
associated with a poor prognosis. However, there are relatively few insights into the genetic …

Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options

RA Mesa, G Barosi, F Cervantes, JT Reilly… - Best Practice & Research …, 2006 - Elsevier
Myelofibrosis with myeloid metaplasia (MMM) is currently classified as a classic (ie not yet
molecularly defined) myeloproliferative disorder (MPD), along with essential …

Prognosis in transplant‐eligible patients with agnogenic myeloid metaplasia: a simple CBC‐based scoring system

D Dingli, SM Schwager, RA Mesa… - … Journal of the …, 2006 - Wiley Online Library
BACKGROUND Allogeneic hematopoietic stem cell transplantation is potentially curative in
agnogenic myeloid metaplasia (AMM) but is associated with substantial mortality and …

Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia

E Rumi, F Passamonti, E Boveri… - American journal of …, 2006 - Wiley Online Library
We report a case of a patient with myelofibrosis with myeloid metaplasia (MMM) who
presented with progressive dyspnea of unexplained origin. Splenomegaly, blood smear …

JAK2V617F and leukemic transformation in myelofibrosis with myeloid metaplasia

RA Mesa, H Powell, T Lasho, G DeWald, R McClure… - Leukemia research, 2006 - Elsevier
Amongst 42 consecutive patients with leukemic transformation (LT) from myelofibrosis with
myeloid metaplasia (MMM) 72% carried the JAK2V617F mutation. The mutation was …

Chronic idiopathic myelofibrosis: clinicopathologic features, pathogenesis, and prognosis

A Ahmed, CC Chang - Archives of pathology & laboratory …, 2006 - meridian.allenpress.com
Context.—Chronic idiopathic myelofibrosis (CIMF) is a clonal myeloproliferative disease
characterized by panmyelosis with intact maturation, progressive bone marrow fibrosis, and …

Advances in the therapy of chronic idiopathic myelofibrosis

C Arana-Yi, A Quintás-Cardama, F Giles… - The …, 2006 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
the clinical manifestations of myelofibrosis with myeloid metaplasia and recent …

Megakaryoblastic differentiation of myeloid sarcoma in a patient with essential thrombocythemia

G Famoso, M Ponzoni, M Freschi, FL Cunsolo… - Leukemia & …, 2006 - Taylor & Francis
Myeloid sarcoma (MS) is a neoplastic growth of myeloblasts or immature myeloid cells
arising in an extra-medullary site or in the bone. MS may precede, occur simultaneously or …

Chronic idiopathic myelofibrosis terminating in extramedullary anaplastic plasmacytoma

ML Liu, B Kallakury, C Kessler, DP Hartmann… - Leukemia & …, 2006 - Taylor & Francis
Chronic idiopathic myelofibrosis (CIMF) is a chronic myeloproliferative disorder (CMPD) with
progressive fibrosis and extramedullary hematopoiesis. Similar to other CMPDs, the stem …